Vital Therapies (VTL) Reports In-Line Q1 EPS

Vital Therapies (NASDAQ: VTL) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c